DCGI

New Delhi: Biological E Ltd (BE) on Saturday announced that it's Covid-19 vaccine Corbevax has been cleared by the Drugs Controller General of India (DCGI) as a heterologous booster for adults who have either received two shots of Covaxin…

New Delhi: Hyderabad-based pharmaceutical giant Biological E Ltd’s coronavirus vaccine Corbevax granted an emergency use approval for use in children aged 12 to 18 years. The Drug Controller General of India (DCGI) on Monday permitted…

Hyderabad: The Drugs Controller General of India (DCGI) approved hydroxyurea for the treatment of sickle cell anaemia. The CSIR-SCA Mission, coordinated by the CSIR-Centre for Cellular and Molecular Biology (CSIR-CCMB) with the help of…

New Delhi: Zydus Cadila has received approval for Emergency Use Authorization (EUA) from the Drug Controller General of India (DCGI) for ZyCoV-D today, the world’s first and India’s indigenously developed DNA based vaccine for COVID-19 to…

New Delhi: Zydus Cadila today announced that the company has applied for Emergency Use Authorization (EUA) to the office of Drug Controller General of India (DCGI) for ZyCoV-D. An approval for Zydus' vaccine, ZyCoV-D, would make it the…

New Delhi: Council of Scientific & Industrial Research (CSIR), and Laxai Life Sciences Pvt. Ltd. Hyderabad, have been given the regulatory approval by DCGI to undertake a two-arm phase-II clinical trial to assess the safety and efficacy…

New Delhi: An anti-COVID-19 therapeutic application of the drug 2-deoxy-D-glucose (2-DG) has been developed by Institute of Nuclear Medicine and Allied Sciences (INMAS), a lab of Defence Research and Development Organisation (DRDO), in…

New Delhi: The Drugs Controller General of India (DCGI) on Monday granted permission to Serum Institute of India (SII) to manufacture its COVID-19 vaccine 'Covishield'. As per reports, the DCGI has also asked Bharat Biotech to submit…

New Delhi: In a major development, the Drug Controller General of India (DCGI) has approved the two vaccines, Oxford-AstraZeneca Covishield and Bharat Biotech's Covaxin, for restricted use in India. The DCGI addressed a press conference…

New Delhi: The Subject Expert Committee of Central Drug Standard Control Organisation has approved emergency use of Oxford-AstraZeneca’s ‘Covishield’ vaccine. The final approval, however, rests with the Drugs Controller General of India…